WCM International Equity Portfolio, 3
Ticker Symbol: FGYZDX

32 Holdings (As of Day of Deposit)
Ticker Company Name Initial Weight Price*
BRAZIL (2.50%)
BOLSY B3 S.A. - Brasil, Bolsa, Balcao 2.50% $4.62
CANADA (3.98%)
CNI Canadian National Railway Company 3.98% 109.16
FRANCE (9.96%)
RI FP Pernod Ricard S.A. 2.49% 110.55
DIM FP Sartorius Stedim Biotech 2.48% 187.01
TTE TotalEnergies SE 4.99% 57.07
GERMANY (2.99%)
HAG GY Hensoldt AG 2.99% 39.28
INDIA (3.00%)
HDB HDFC Bank Ltd. 3.00% 66.70
IRELAND (3.06%)
AON Aon Plc  3.06% 385.56
JAPAN (5.26%)
3769 JP GMO Payment Gateway, Inc. 2.01% 54.27
4612 JP Nippon Paint Holdings Co., Ltd. 3.25% 7.02
MEXICO (2.50%)
MEGACPO MM Megacable Holdings, S.A.B. de C.V. (Unit) 2.50% 1.90
THE NETHERLANDS (5.50%)
ADYEY Adyen N.V. 3.00% 14.68
ASM NA ASM International N.V. 2.50% 538.18
SINGAPORE (4.00%)
UOB SP United Overseas Bank Limited 4.00% 27.32
SPAIN (3.50%)
IBDRY Iberdrola S.A. 3.50% 56.79
SWEDEN (5.50%)
BRAV SS Bravida Holding AB 3.00% 7.09
EPIA SS Epiroc AB  2.50% 18.80
TAIWAN (3.95%)
TSM Taiwan Semiconductor Manufacturing Company Ltd. 3.95% 198.89
UNITED KINGDOM (31.08%)
AZN AstraZeneca Plc 5.00% 68.05
CPG LN Compass Group Plc 3.51% 34.59
CTEC LN ConvaTec Group Plc 2.50% 2.97
GSK GSK Plc 2.50% 34.90
HLN Haleon Plc 3.50% 9.71
LSEG LN London Stock Exchange Group Plc 3.04% 143.51
PSN LN Persimmon Plc 4.01% 15.79
SPX LN Spirax Group Plc 4.02% 93.48
WISE LN Wise Plc  3.00% 11.41
UNITED STATES (10.66%)
FCX Freeport-McMoRan Inc. 2.00% 43.83
MA Mastercard Incorporated 2.44% 526.18
NKE NIKE, Inc.  2.77% 78.86
VEEV Veeva Systems Inc.  3.45% 226.46
URUGUAY (2.56%)
MELI MercadoLibre, Inc. 2.56% 1,929.49

*As of the close of business on 12/3/24. Market values are for reference only and are not indicative of your individual cost basis.

Not FDIC Insured • Not Bank Guaranteed • May Lose Value

Portfolio Summary
Initial Date of Deposit 12/4/2024
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 3/4/2026
Cash CUSIP 30339C649
Reinvestment CUSIP 30339C656
Fee Accounts Cash CUSIP 30339C664
Fee Accounts Reinvestment CUSIP 30339C672

Fee Table (based on a $10 public offering price per unit)
  Standard Fee/Wrap
Deferred Sales Charge 1.35%
Creation & Development Fee (C&D Fee) 0.50% 0.50%
Maximum Sales Charge 1.85% 0.50%
     
Estimated Organization Costs 0.690% 0.690%
Estimated Annual Trust Operating Expenses 0.457% 0.457%

The deferred sales charge will be deducted in three monthly installments commencing 3/20/25. When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge. The C&D fee is a charge of $0.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the C&D fee will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will exceed 0.50%. Estimated organization costs will be deducted from the assets of the trust at the end of the initial offering period. Estimated organization costs and trust operating expenses are assessed on a fixed dollar amount per unit basis which, as a percentage of average net assets, will vary over time. Actual expenses may be more or less than the estimates. Please see “Fee Table” in the trust prospectus for additional information.

You should consider the portfolio's investment objectives, risks, and charges and expenses carefully before investing. Contact your financial professional or call First Trust Portfolios L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.

Risk Considerations

An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

You should be aware that the portfolio is concentrated in stocks in the financials sector which involves additional risks, including limited diversification. The companies engaged in the financials sector are subject to the adverse effects of volatile interest rates, economic recession, decreases in the availability of capital, increased competition from new entrants in the field, and potential increased regulation.

A significant percentage of the securities held in the trust are issued by companies headquartered or incorporated in Europe, which may present more risks than a portfolio which is broadly diversified over several regions.

Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers. Risks associated with investing in non-U.S. securities may be more pronounced in emerging markets where the securities markets are substantially smaller, less developed, less liquid, less regulated, and more volatile than the U.S. and developed non-U.S. markets.

An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

Large capitalization companies may grow at a slower rate than the overall market.

As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.

Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East have caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.

A public health crisis, and the ensuing policies enacted by governments and central banks in response, could cause significant volatility and uncertainty in global financial markets, negatively impacting global growth prospects.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.

 

CUSIP identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by FactSet Research Systems Inc. and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, ©2024 CUSIP Global Services. "CUSIP" is a registered trademark of the American Bankers Association.